Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates

BACKGROUND: Pharmacogenomic (PGx) testing has proved its utility and cost-effectiveness for some commonly prescribed cardiovascular disease (CVD) medications. In addition, PGx-guided dosing guidelines are now available for multiple CVD drugs, including clopidogrel, warfarin, and statins. The United...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mahayri, Zeina N., Khasawneh, Lubna Q., Alqasrawi, Mais N., Altoum, Sahar M., Jamil, Gohar, Badawi, Sally, Hamza, Dana, George, Lizy, AlZaabi, Anwar, Ouda, Husam, Al-Maskari, Fatma, AlKaabi, Juma, Patrinos, George P., Ali, Bassam R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509637/
https://www.ncbi.nlm.nih.gov/pubmed/36154845
http://dx.doi.org/10.1186/s40246-022-00417-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509637/
https://www.ncbi.nlm.nih.gov/pubmed/36154845
http://dx.doi.org/10.1186/s40246-022-00417-9

Ejemplares similares